Skip to Main Content

Paper Details

MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer.
Sci Rep
20
2021
Author NameAffiliation
Sharon J PitteriStanford University
Sharon J PitteriStanford University
Eva CoreyUniversity of Washington
  • 1 - 3

Datasets